Keywords: آنتی بادی HLA; lung transplantation; rejection; HLA antibodies; allograft dysfunction;
مقالات ISI آنتی بادی HLA (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آنتی بادی HLA; HLA antibodies; solid-phase assays; virtual crossmatch; heart transplantation; donor specific antibodies;
Keywords: آنتی بادی HLA; HLA antibodies; lung transplant; single-antigen flow beads; biopsy; antibody-mediated rejection;
Keywords: آنتی بادی HLA; Kidney transplantation; kidney transplant recipient (KTR); HLA antibodies; sensitization; RBC transfusion; donor-specific antibody (DSA); solid-phase immunoassay; crossmatching; allograft nephrectomy; acute rejection; allograft function; graft survival; r
Keywords: آنتی بادی HLA; Single antigen bead; HLA antibodies; Donor-specific antibodies; sCD30; Kidney transplantation; Graft outcome
Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies
Keywords: آنتی بادی HLA; Kidney transplant; Deceased donor; Acute rejection; Donor-specific antibodies; HLA-antibodies; %PRA; panel reactive antibody percentage; AMR; antibody mediated rejection; ACR; acute cellular rejection; AR; acute rejection; CDC; complement-dependent cytoto
Donor-specific HLA antibodies in predicting crossmatch outcome: Comparison of three different laboratory techniques
Keywords: آنتی بادی HLA; Crossmatch; Donor-specific antibodies; HLA antibodies; Kidney transplantation; Solid-phase assay; AUC; area under curve; CDC; Complement-dependent cytotoxicity; CDCXM; Complement-dependent cytotoxicity crossmatch; DSA; donor specific antibodies; DTT; dith
Rapid optimized flow cytometric crossmatch (FCXM) assays: The Halifax and Halifaster protocols
Keywords: آنتی بادی HLA; 3SD; 3 standard deviations; CDC; complement-dependent cytotoxicity; DSA; donor-specific HLA antibodies; FCXM; flow cytometry crossmatch; FWB; flow wash buffer; HLA; human leukocyte antigen; MCF; median channel fluorescence; MCFS; median channel fluorescen
Pretransplant serum BAFF levels are associated with pretransplant HLA immunization and renal allograft survival
Keywords: آنتی بادی HLA; BAFF; HLA antibodies; Allosensitization; Antibody-mediated rejection; Renal allograft survival; Ab; antibody; ACR; acute T cell-mediated rejection; AMR; antibody-mediated rejection; ATG; anti-thymocyte globulin; BAFF; B cell-activating factor; BAFF-R;
Epitope analysis of DQ6-reactive antibodies in sera from a DQ6-positive transplant candidate sensitized during pregnancy
Keywords: آنتی بادی HLA; HLA; HLAMatchmaker; HLA antibodies; Epitope; Nonself-self;
High background in Luminex® assay for HLA antibody screening: Interest of Adsorb Out™
Keywords: آنتی بادی HLA; Luminex; HLA antibodies; High negative control bead value; Adsorb Out™
Impact of pretransplant exposure to allosensitization factors generating HLA antibodies in the Luminex era
Keywords: آنتی بادی HLA; HLAab; HLA antibodies; PRA; panel reactive antibody; RT; room temperature; SD; standard deviation; OR; Odds ratio; CKD; chronic kidney disease; KTx; kidney transplantation; prevKTx; previous kidney transplant; Allosensitization factor; Waiting list; Kidne
HLA-C antibodies in women with recurrent miscarriage suggests that antibody mediated rejection is one of the mechanisms leading to recurrent miscarriage
Keywords: آنتی بادی HLA; LMWH; low molecular weight heparin; LUMC; Leiden University Medical Centre; HLA antibodies; Humoral rejection; Immunology; Pregnancy; Recurrent miscarriage;
CPRA for allocation of kidneys in the US: More candidates ≥98% CPRA, lower positive crossmatch rates and improved transplant rates for sensitized patients
Keywords: آنتی بادی HLA; CPRA; HLA antibodies; Sensitization; Crossmatch; Kidney transplant
Clinical relevance of circulating antibodies and B lymphocyte markers in allograft rejection
Keywords: آنتی بادی HLA; Transplantation; B cells; Donor specific antibodies; HLA antibodies; Non-HLA antibodies; Antibody-mediated rejection; Complement; Luminex
Epitope-specificities of HLA antibodies: The effect of epitope structure on Luminex technique-dependent antibody reactivity
Keywords: آنتی بادی HLA; HLA, human leukocyte antigen; CDC, complement-dependent cytotoxicity; CDCXM, complement-dependent cytotoxicity crossmatch; MFI, median fluorescence intensity; PRA, panel reactive antibody; SA, single antigenEplet; HLA antibodies; Luminex; HLAMatchmaker; H
Pregnancy-induced HLA antibodies respond more vigorously after renal transplantation than antibodies induced by prior transplantation
Keywords: آنتی بادی HLA; ATG; anti-thymocyte globulin; CDC; complement dependent cytotoxicity; DSA; donor specific antibody; FC; flow cytometry; IQR; interquartile range; MFI; mean fluorescence intensity; HLA antibodies; Antibody incompatible kidney transplantation; Antibody medi
Effect of persistent versus transient donor-specific HLA antibodies on graft outcomes in pediatric cardiac transplantation
Keywords: آنتی بادی HLA; donor-specific; HLA antibodies; pediatric cardiac transplantation; graft outcomes;
Improved flow cytometry based cytotoxicity and binding assay for clinical antibody HLA crossmatching
Keywords: آنتی بادی HLA; HLA antibodies; Transplantation; Complement-dependent lymphocytotoxicity; Flow cytometry crossmatch; C1q assay
The perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejection
Keywords: آنتی بادی HLA; organ transplantation; antibody-mediated rejection; HLA antibodies; classical complement pathway
Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation
Keywords: آنتی بادی HLA; desensitization; HLA antibodies; renal transplantation; rituximab;
HLA and MICA allosensitization patterns among patients supported by ventricular assist devices
Keywords: آنتی بادی HLA; heart transplantation; VAD; allosensitization; HLA antibodies; MICA antibodies; antibody detection;
Low median fluorescence intensity could be a nonsafety concept of immunologic risk evaluation in patients with shared molecular eplets in kidney transplantation
Keywords: آنتی بادی HLA; Kidney transplant; Median fluorescence intensity; Epitopes; Cross-matching; HLA antibodies
Predicting renal graft failure by sCD30 levels and de novo HLA antibodies at 1Â year post-transplantation
Keywords: آنتی بادی HLA; HLA antibodies; Soluble CD30; Renal transplantation; Graft loss;
Proteasome inhibition by bortezomib: Effect on HLA-antibody levels and specificity in sensitized patients awaiting renal allograft transplantation
Keywords: آنتی بادی HLA; AMR; antibody mediated rejection; ATG; antithymocyte globulin; CDC; complement-dependent lymphocytotoxic; HLA; human leucocyte antigen; Ig; immunoglobulin; IL; interleukin; IVIG; intravenous immunoglobulin; MFI; mean fluorescence intensity; PRA; panel rea
Clinically irrelevant circulating human leukocyte antigen antibodies in the presence of ventricular assist devices
Keywords: آنتی بادی HLA; natural antibodies; HLA antibodies; heart transplant; sensitization; patients with LVAD;
HLA techniques: Typing and antibody detection in the laboratory of immunogenetics
Keywords: آنتی بادی HLA; Cross-match; HLA antigens; HLA antibodies; PCR-SSP; PCR-SSO; PCR-SSO rev; PCR-SBT
Brief report: Why did two patients who type for HLA-B13 have antibodies that react with all Bw4 antigens except HLA-B13?
Keywords: آنتی بادی HLA; HLA; HLAMatchmaker; HLA antibodies; Epitope; Eplet; Nonself-self;
Human leukocyte antigen sensitization after transplant loss: timing of antibody detection and implications for prevention
Keywords: آنتی بادی HLA; Sensitization; HLA antibodies; Renal transplants; Graft loss; Immunosuppression
Prevalence and qualitative properties of circulating anti-human leukocyte antigen alloantibodies after pregnancy: No association with unexplained recurrent miscarriage
Keywords: آنتی بادی HLA; Abortion; Complement activation; HLA antibodies; Pregnancy; Recurrent miscarriage;
Donor human leukocyte antigen specific antibodies predict development and define prognosis in transplant glomerulopathy
Keywords: آنتی بادی HLA; HLA antibodies; Renal transplant; Glomerulopathy
Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads
Keywords: آنتی بادی HLA; HLA antibodies; Transplantation; Antibody-mediated rejection; Complement; Donor-specific antibodies
High-resolution, three-dimensional modeling of human leukocyte antigen class I structure and surface electrostatic potential reveals the molecular basis for alloantibody binding epitopes
Keywords: آنتی بادی HLA; Alloantigen immunogenicity; HLA antibodies
Specific “intra-allele” and “intra–broad antigen” human leukocyte antigen alloantibodies in kidney graft transplantation
Keywords: آنتی بادی HLA; Kidney transplant; Crossmatching; HLA antibodies; Graft loss
Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: A 30-month analysis in living donor kidney transplantation
Keywords: آنتی بادی HLA; Kidney transplantation; HLA antibodies; Virtual crossmatch; DSA;
New HLA class I epitopes defined by murine monoclonal antibodies
Keywords: آنتی بادی HLA; HLA epitopes; HLA antibodies; Monoclonal antibodies; SA beads
Emerging role of B cells in chronic allograft dysfunction
Keywords: آنتی بادی HLA; chronic allograft nephropathy; C4d; HLA antibodies; renal allograft; transplant glomerulopathy;
Human leukocyte antigen antibody detection and kidney allocation within Eurotransplant
Keywords: آنتی بادی HLA; HLA antibodies; Kidney allocation; Eurotransplant
Clinical relevance of complement-fixing antibodies in cardiac transplantation
Keywords: آنتی بادی HLA; Cardiac transplantation; Alloantibodies; Non-HLA antibodies; Complement; HLA antibodies
Clinical significance of anti-HLA antibodies detected by Luminex®: Enhancing the interpretation of CDC-BXM and important post-transplantation monitoring tools
Keywords: آنتی بادی HLA; HLA antibodies; Luminex®; Crossmatch; Renal transplantation; Monitoring
Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: A Collaborative Transplant Study report
Keywords: آنتی بادی HLA; HLA antibodies; Kidney transplantation; Solid phase; ELISA; Graft outcome
Peripheral blood B cells producing donor-specific HLA antibodies in vitro
Keywords: آنتی بادی HLA; B cells; Antibody production; HLA antibodies; Donor-specific antibodies; IgG/IgM
Donor-reactive HLA antibodies in renal allograft recipients: Considerations, complications, and conundrums
Keywords: آنتی بادی HLA; HLA antibodies; HLA antigens; HLA alleles; Donor-directed antibodies; Solid phase assays
Detecting and monitoring human leukocyte antigen–specific antibodies
Keywords: آنتی بادی HLA; HLA antibodies; Antibody monitoring; Solid phase immunoassays
A non-allogeneic stimulus triggers the production of de novo HLA antibodies in healthy adults
Keywords: آنتی بادی HLA; Allogeneic; HLA antibodies; PRA; Vaccination
Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss
Keywords: آنتی بادی HLA; Kidney transplantation; HLA antibodies; Soluble CD30; Graft survival
HLA Class I Epitopes: Recognition of Binding Sites by mAbs or Eluted Alloantibody Confirmed With Single Recombinant Antigens
Keywords: آنتی بادی HLA; HLA Epitopes; HLA antibodies; HLA public antibodies; HLA crossreactions
The relationship of nodular endocardial infiltrates (Quilty lesions) to survival, patient age, anti-HLA antibodies, and coronary artery disease following heart transplantation
Keywords: آنتی بادی HLA; Quilty lesions; HLA antibodies; Heart transplantation;
The Single Antigen expressing Lines (SALs) Concept: An Excellent Tool for Screening for HLA-Specific Antibodies
Keywords: آنتی بادی HLA; Highly sensitized; HLA antibodies; kidney transplantation; K562; screening; AM; acceptable mismatch; CDC; complement-dependent cytotoxicity; FCM; flow cytometry; ELISA; enzyme-linked immunosorbent assay; HLA; human leukocyte antigen; HuMAb; human monoclon